《盈利预喜》人瑞人才(06919.HK)料去年扭亏 录纯利1.6亿至1.75亿人币
人瑞人才(06919.HK)发盈喜,预期截至去年12月底止年度,收益按年增长20%至30%,纯利约1.6亿元人民币(下同)至1.75亿元,相对於2019年度为净亏损约7.8亿元。
公司解释,主因股份於2019年12月在联交所上市後,由若干首次公开发售前投资者所持有的优先股转换为公司普通股後,在2020年财政年度并无产生复合金融工具公平值亏损;疫情於2020年财政年度下半年的影响逐渐减退,集团的业务已得到改善。
上述估计的2020年财政年度纯利较2019年同期的经调整纯利约1.34亿元增加约20%至30%,主要是由於集团业务改善,导致收益增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.